Role of phalatrikadi ghana in Fatty Liver
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2023/11/059886
- Lead Sponsor
- Institute of Medical Science Department of Rasa Shastra evum Bhaishajya Kalpana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Patient of either sex, between the age group of 20 to 60 yrs, Sonologically diagnosed cases of fatty liver.
•Fatty liver of grade I, II, III will be enrolled for clinical trial.
•Patients having any of the components of metabolic syndrome, i.e., obesity, hypertension, diabetes mellitus, hypertriglyceridemia.
•BMI >25, presenting with the symptoms of indigestion, abdominal discomfort, flatulence, etc.
Exclusion Criteria
Alcoholic stetohepatitis, Hepatitis B and C, cirrhosis of liver, jaundice, pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method